Erleada Clinical Study Report Is First Release In Drug Review Transparency Pilot

 
• By Bridget Silverman

US FDA publishes 1,000+ page CSR for J&J's prostate cancer drug, and eight more products will follow. But how useful will the extra information be?

bundles bales of paper documents. stacks packs pile on the desk in the office

More from Clinical Trials

More from R&D